Try our beta test site

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Singapore (DiabCare Asia)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT00836030
First received: January 30, 2009
Last updated: November 21, 2016
Last verified: November 2016

January 30, 2009
November 21, 2016
January 2009
April 2009   (Final data collection date for primary outcome measure)
  • Mean age of onset of type 1 and 2 diabetes mellitus [ Time Frame: at baseline visit/study start ]
  • Mean duration of treatment of type 2 DM [ Time Frame: at baseline visit/study start ]
  • Percentage of patients on Insulin and OAD therapy [ Time Frame: at baseline visit/study start ]
  • Mean duration of diabetes in type 1 and type 2 patients respectively [ Time Frame: at baseline visit/study start ]
  • Mean FPG and PPG of diabetic patients [ Time Frame: at baseline visit/study start ]
  • Mean HbA1c of diabetic patients [ Time Frame: at baseline visit/study start ]
  • Percentage of diabetic patients with HbA1c target below or equal to 7.0% [ Time Frame: at baseline visit/study start ]
  • Percentage of diabetic patients with HbA1c target below or equal to 6.5% [ Time Frame: at baseline visit/study start ]
  • Percentage of diabetic patients having dyslipidemia and hypertension [ Time Frame: at baseline visit/study start ]
  • Percentage of diabetic patients having cardiovascular complications [ Time Frame: at baseline visit/study start ]
  • Percentage of diabetic patients having peripheral vascular disease [ Time Frame: at baseline visit/study start ]
  • Percentage of diabetic patients having diabetic nephropathy [ Time Frame: at baseline visit/study start ]
  • Percentage of diabetic patients having diabetic eye complications [ Time Frame: at baseline visit/study start ]
Same as current
Complete list of historical versions of study NCT00836030 on ClinicalTrials.gov Archive Site
  • Patients' perception will be analysed through Patient questionnaire measuring - Psychological well-being, Quality of life, Patients' compliant to treatment [ Time Frame: at baseline visit/study start ]
  • Physician perception of diabetes and its management will be analysed through Physician questionnaire measuring awareness about - HbA1c test and its goal, Anti-diabetic treatment, Barriers towards optimum diabetes control [ Time Frame: at baseline visit/study start ]
  • Duration of diabetes associated with highest number of diabetic complications [ Time Frame: at baseline visit/study start ]
  • Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, Nephropathy and retinopathy) [ Time Frame: at baseline visit/study start ]
Same as current
Not Provided
Not Provided
 
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Singapore
DiabCare Asia 2008. A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia and To Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in Asia
This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control and complications in diabetic subjects in Asia.
Not Provided
Observational
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples With DNA
Description:
Blood sample
Non-Probability Sample
Patients with diabetes mellitus (both type 1 and type 2) being treated at general hospitals, diabetes clinics and referral clinics will be selected according to the inclusion and exclusion criteria.
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
Other: No treatment given
No treatment given
A
Intervention: Other: No treatment given
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
854
April 2009
April 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diabetic patients registered in the particular centre for more than 12 months
  • Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit
  • Patients willing to sign informed consent form

Exclusion Criteria:

  • Repetition of any patient as patients should not be included twice for any reason
  • Unwilling to participate or unable to comply with protocol requirements
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Singapore
 
 
NCT00836030
INS-3710
No
Not Provided
Not Provided
Not Provided
Novo Nordisk A/S
Novo Nordisk A/S
Not Provided
Study Director: Global Clinical Registry (GCR, 1452) Novo Nordisk A/S
Novo Nordisk A/S
November 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP